In vitro activities of various piperacillin and sulbactam combinations against bacterial pathogens isolated from Intensive Care Units in Taiwan

SMART 2004 programme data

Min Nan Hung, Po Ren Hsueh, Hou Tai Chang, Wen Sen Lee, Ming Yuan Chou, Ing Shen Chen, Jen Hsien Wang, Chen Fu Lin, Jainn Ming Shyr, Wen Chien Ko, Jiunn Jong Wu, Yung Ching Liu, Wen Kuei Huang, Lee Jene Teng, Cheng Yi Liu, Kwen Tay Luh

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

We investigated the in vitro activity of various piperacillin and sulbactam combinations against Gram-negative bacterial isolates from Intensive Care Units (ICUs) in Taiwan. Antimicrobial susceptibility testing of 1030 bacterial isolates recovered from ICUs of nine major teaching hospitals was performed using the agar dilution method. Sulbactam was added to piperacillin either at a fixed sulbactam concentration of 4 mg/L and 8 mg/L or at a piperacillin:sulbactam ratio of 2:1 and 4:1. Piperacillin/sulbactam at a ratio of 2:1 or a fixed 8 mg/L concentration of sulbactam had better activities against Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis and Serratia marcescens than other piperacillin/sulbactam formulations. For Pseudomonas aeruginosa, piperacillin/sulbactam (2:1 or 4:1 ratios) had MIC90 values (minimum inhibitory concentration for 90% of the organisms) of 64 mg/L (>90% susceptibility) compared with 64 mg/L for cefoperazone/sulbactam (68% susceptibility) and 128 mg/L for piperacillin/tazobactam (82% susceptibility). For Acinetobacter baumannii, both piperacillin/sulbactam (either 2:1 ratio or a fixed 8 mg/L sulbactam) and cefoperazone/sulbactam were the most potent agents. Adding sulbactam to piperacillin resulted in increased susceptibility rates among piperacillin-resistant P. aeruginosa (53-57% in either 2:1 or 4:1 ratios) and A. baumannii (38-46% in either 2:1 ratio or a fixed 8 mg/L concentration of sulbactam) isolates. Results of susceptibility tests with piperacillin/sulbactam are dependent on the method used. Piperacillin/sulbactam combinations possessed better in vitro activities than piperacillin alone or piperacillin/tazobactam against P. aeruginosa and A. baumannii.

Original languageEnglish
Pages (from-to)145-152
Number of pages8
JournalInternational Journal of Antimicrobial Agents
Volume29
Issue number2
DOIs
Publication statusPublished - Feb 2007
Externally publishedYes

Fingerprint

Sulbactam
Piperacillin
Taiwan
Intensive Care Units
Acinetobacter baumannii
Pseudomonas aeruginosa
Cefoperazone
In Vitro Techniques
Proteus mirabilis
Serratia marcescens
Klebsiella pneumoniae
Microbial Sensitivity Tests

Keywords

  • A. baumannii
  • P. aeruginosa
  • Piperacillin
  • Piperacillin/tazobactam
  • Sulbactam

ASJC Scopus subject areas

  • Applied Microbiology and Biotechnology
  • Microbiology
  • Parasitology
  • Virology
  • Immunology and Allergy
  • Infectious Diseases

Cite this

In vitro activities of various piperacillin and sulbactam combinations against bacterial pathogens isolated from Intensive Care Units in Taiwan : SMART 2004 programme data. / Hung, Min Nan; Hsueh, Po Ren; Chang, Hou Tai; Lee, Wen Sen; Chou, Ming Yuan; Chen, Ing Shen; Wang, Jen Hsien; Lin, Chen Fu; Shyr, Jainn Ming; Ko, Wen Chien; Wu, Jiunn Jong; Liu, Yung Ching; Huang, Wen Kuei; Teng, Lee Jene; Liu, Cheng Yi; Luh, Kwen Tay.

In: International Journal of Antimicrobial Agents, Vol. 29, No. 2, 02.2007, p. 145-152.

Research output: Contribution to journalArticle

Hung, Min Nan ; Hsueh, Po Ren ; Chang, Hou Tai ; Lee, Wen Sen ; Chou, Ming Yuan ; Chen, Ing Shen ; Wang, Jen Hsien ; Lin, Chen Fu ; Shyr, Jainn Ming ; Ko, Wen Chien ; Wu, Jiunn Jong ; Liu, Yung Ching ; Huang, Wen Kuei ; Teng, Lee Jene ; Liu, Cheng Yi ; Luh, Kwen Tay. / In vitro activities of various piperacillin and sulbactam combinations against bacterial pathogens isolated from Intensive Care Units in Taiwan : SMART 2004 programme data. In: International Journal of Antimicrobial Agents. 2007 ; Vol. 29, No. 2. pp. 145-152.
@article{3ec52e15c8bc48f29642c5c5789371aa,
title = "In vitro activities of various piperacillin and sulbactam combinations against bacterial pathogens isolated from Intensive Care Units in Taiwan: SMART 2004 programme data",
abstract = "We investigated the in vitro activity of various piperacillin and sulbactam combinations against Gram-negative bacterial isolates from Intensive Care Units (ICUs) in Taiwan. Antimicrobial susceptibility testing of 1030 bacterial isolates recovered from ICUs of nine major teaching hospitals was performed using the agar dilution method. Sulbactam was added to piperacillin either at a fixed sulbactam concentration of 4 mg/L and 8 mg/L or at a piperacillin:sulbactam ratio of 2:1 and 4:1. Piperacillin/sulbactam at a ratio of 2:1 or a fixed 8 mg/L concentration of sulbactam had better activities against Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis and Serratia marcescens than other piperacillin/sulbactam formulations. For Pseudomonas aeruginosa, piperacillin/sulbactam (2:1 or 4:1 ratios) had MIC90 values (minimum inhibitory concentration for 90{\%} of the organisms) of 64 mg/L (>90{\%} susceptibility) compared with 64 mg/L for cefoperazone/sulbactam (68{\%} susceptibility) and 128 mg/L for piperacillin/tazobactam (82{\%} susceptibility). For Acinetobacter baumannii, both piperacillin/sulbactam (either 2:1 ratio or a fixed 8 mg/L sulbactam) and cefoperazone/sulbactam were the most potent agents. Adding sulbactam to piperacillin resulted in increased susceptibility rates among piperacillin-resistant P. aeruginosa (53-57{\%} in either 2:1 or 4:1 ratios) and A. baumannii (38-46{\%} in either 2:1 ratio or a fixed 8 mg/L concentration of sulbactam) isolates. Results of susceptibility tests with piperacillin/sulbactam are dependent on the method used. Piperacillin/sulbactam combinations possessed better in vitro activities than piperacillin alone or piperacillin/tazobactam against P. aeruginosa and A. baumannii.",
keywords = "A. baumannii, P. aeruginosa, Piperacillin, Piperacillin/tazobactam, Sulbactam",
author = "Hung, {Min Nan} and Hsueh, {Po Ren} and Chang, {Hou Tai} and Lee, {Wen Sen} and Chou, {Ming Yuan} and Chen, {Ing Shen} and Wang, {Jen Hsien} and Lin, {Chen Fu} and Shyr, {Jainn Ming} and Ko, {Wen Chien} and Wu, {Jiunn Jong} and Liu, {Yung Ching} and Huang, {Wen Kuei} and Teng, {Lee Jene} and Liu, {Cheng Yi} and Luh, {Kwen Tay}",
year = "2007",
month = "2",
doi = "10.1016/j.ijantimicag.2006.02.017",
language = "English",
volume = "29",
pages = "145--152",
journal = "International Journal of Antimicrobial Agents",
issn = "0924-8579",
publisher = "Elsevier",
number = "2",

}

TY - JOUR

T1 - In vitro activities of various piperacillin and sulbactam combinations against bacterial pathogens isolated from Intensive Care Units in Taiwan

T2 - SMART 2004 programme data

AU - Hung, Min Nan

AU - Hsueh, Po Ren

AU - Chang, Hou Tai

AU - Lee, Wen Sen

AU - Chou, Ming Yuan

AU - Chen, Ing Shen

AU - Wang, Jen Hsien

AU - Lin, Chen Fu

AU - Shyr, Jainn Ming

AU - Ko, Wen Chien

AU - Wu, Jiunn Jong

AU - Liu, Yung Ching

AU - Huang, Wen Kuei

AU - Teng, Lee Jene

AU - Liu, Cheng Yi

AU - Luh, Kwen Tay

PY - 2007/2

Y1 - 2007/2

N2 - We investigated the in vitro activity of various piperacillin and sulbactam combinations against Gram-negative bacterial isolates from Intensive Care Units (ICUs) in Taiwan. Antimicrobial susceptibility testing of 1030 bacterial isolates recovered from ICUs of nine major teaching hospitals was performed using the agar dilution method. Sulbactam was added to piperacillin either at a fixed sulbactam concentration of 4 mg/L and 8 mg/L or at a piperacillin:sulbactam ratio of 2:1 and 4:1. Piperacillin/sulbactam at a ratio of 2:1 or a fixed 8 mg/L concentration of sulbactam had better activities against Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis and Serratia marcescens than other piperacillin/sulbactam formulations. For Pseudomonas aeruginosa, piperacillin/sulbactam (2:1 or 4:1 ratios) had MIC90 values (minimum inhibitory concentration for 90% of the organisms) of 64 mg/L (>90% susceptibility) compared with 64 mg/L for cefoperazone/sulbactam (68% susceptibility) and 128 mg/L for piperacillin/tazobactam (82% susceptibility). For Acinetobacter baumannii, both piperacillin/sulbactam (either 2:1 ratio or a fixed 8 mg/L sulbactam) and cefoperazone/sulbactam were the most potent agents. Adding sulbactam to piperacillin resulted in increased susceptibility rates among piperacillin-resistant P. aeruginosa (53-57% in either 2:1 or 4:1 ratios) and A. baumannii (38-46% in either 2:1 ratio or a fixed 8 mg/L concentration of sulbactam) isolates. Results of susceptibility tests with piperacillin/sulbactam are dependent on the method used. Piperacillin/sulbactam combinations possessed better in vitro activities than piperacillin alone or piperacillin/tazobactam against P. aeruginosa and A. baumannii.

AB - We investigated the in vitro activity of various piperacillin and sulbactam combinations against Gram-negative bacterial isolates from Intensive Care Units (ICUs) in Taiwan. Antimicrobial susceptibility testing of 1030 bacterial isolates recovered from ICUs of nine major teaching hospitals was performed using the agar dilution method. Sulbactam was added to piperacillin either at a fixed sulbactam concentration of 4 mg/L and 8 mg/L or at a piperacillin:sulbactam ratio of 2:1 and 4:1. Piperacillin/sulbactam at a ratio of 2:1 or a fixed 8 mg/L concentration of sulbactam had better activities against Escherichia coli, Klebsiella pneumoniae, Proteus mirabilis and Serratia marcescens than other piperacillin/sulbactam formulations. For Pseudomonas aeruginosa, piperacillin/sulbactam (2:1 or 4:1 ratios) had MIC90 values (minimum inhibitory concentration for 90% of the organisms) of 64 mg/L (>90% susceptibility) compared with 64 mg/L for cefoperazone/sulbactam (68% susceptibility) and 128 mg/L for piperacillin/tazobactam (82% susceptibility). For Acinetobacter baumannii, both piperacillin/sulbactam (either 2:1 ratio or a fixed 8 mg/L sulbactam) and cefoperazone/sulbactam were the most potent agents. Adding sulbactam to piperacillin resulted in increased susceptibility rates among piperacillin-resistant P. aeruginosa (53-57% in either 2:1 or 4:1 ratios) and A. baumannii (38-46% in either 2:1 ratio or a fixed 8 mg/L concentration of sulbactam) isolates. Results of susceptibility tests with piperacillin/sulbactam are dependent on the method used. Piperacillin/sulbactam combinations possessed better in vitro activities than piperacillin alone or piperacillin/tazobactam against P. aeruginosa and A. baumannii.

KW - A. baumannii

KW - P. aeruginosa

KW - Piperacillin

KW - Piperacillin/tazobactam

KW - Sulbactam

UR - http://www.scopus.com/inward/record.url?scp=33846089005&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=33846089005&partnerID=8YFLogxK

U2 - 10.1016/j.ijantimicag.2006.02.017

DO - 10.1016/j.ijantimicag.2006.02.017

M3 - Article

VL - 29

SP - 145

EP - 152

JO - International Journal of Antimicrobial Agents

JF - International Journal of Antimicrobial Agents

SN - 0924-8579

IS - 2

ER -